Acumen Pharmaceuticals, Inc. (ABOS) 是一家上市公司 屬於 醫療保健 板塊，經營於 生物科技 產業. 公司總部位於 Newton, VA, 美国. 現任CEO為 James Doherty.
ABOS 擁有 IPO日期為 2021-07-01, 61 名全職員工, 在 NASDAQ Global Select, 市值為 $162.34M.
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
